Aurinia Pharmaceuticals Inc. (AUPH) revenue

Revenue · fiscal 2025
$283.06M

Aurinia Pharmaceuticals Inc. (AUPH) reported revenue of $283.06M in fiscal 2025 (the year ended December 31, 2025). That is 20.4% higher than the $235.13M of fiscal 2024. Figures as of 18 Nov 2026, 10:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$283.06M
Change on fiscal 2024
+20.4%
Growth, 5 years
+41.4% a year
Highest on record
$283.06Mfiscal 2025
Lowest on record
$318.00Kfiscal 2019
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Aurinia Pharmaceuticals Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 41.4% a year. Across the 8 fiscal years on record (2018–2025), the highest was $283.06M in fiscal 2025 and the lowest $318.00K in fiscal 2019.

History · 8 fiscal years

Revenue by fiscal year

Aurinia Pharmaceuticals Inc. revenue, year by year

Aurinia Pharmaceuticals Inc. (AUPH) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$283.06M 20.4% up
2024$235.13M 34.0% up
2023$175.51M 31.0% up
2022$134.03M 193.9% up
2021$45.61M 9.0% down
2020$50.12M 15,660.4% up
2019$318.00K 31.3% down
2018$463.00K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on AUPH

Aurinia Pharmaceuticals Inc., figure by figure

Aurinia Pharmaceuticals Inc. (AUPH) overview: price, valuation and scorecard

Aurinia Pharmaceuticals Inc. revenue: questions and answers

What is Aurinia Pharmaceuticals Inc.'s revenue?

Aurinia Pharmaceuticals Inc. (AUPH) reported revenue of $283.06M in fiscal 2025 (the year ended December 31, 2025). That is 20.4% higher than the $235.13M of fiscal 2024.

What is the growth rate of Aurinia Pharmaceuticals Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 41.4% a year.

What are the highest and lowest revenue figures on record for Aurinia Pharmaceuticals Inc.?

Across the 8 fiscal years on record (2018–2025), the highest was $283.06M in fiscal 2025 and the lowest $318.00K in fiscal 2019.

How is Aurinia Pharmaceuticals Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Aurinia Pharmaceuticals Inc. it is on record here for 8 fiscal years, 2018 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Aurinia Pharmaceuticals Inc. (AUPH) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/AUPH/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.